4 results  1 of 1 

1 Lipid Profile Changes after Switch to Atazanavir from other Protease Inhibitor-based Combined Antiretroviral Treatment in HIV-infected Korean
Ji Hyeon Baek, Young Goo Song, Chang Oh Kim, Su Jin Jeong, Nam Soo Koo, Hye Won Kim, Sang Hoon Han, Jun Yong Choi, June Myung Kim
Infect Chemother.2012;44(5):377-381.   Published online 2012 October 31     DOI: http://dx.doi.org/10.3947/ic.2012.44.5.377
      
2 Effect of Ritonavir-boosting on Atazanavir Discontinuation due to Jaundice in HIV-infected Koreans
Pyoeng Gyun Choe, Wan Beom Park, Kyoung-Ho Song, Ji-Hwan Bang, Eu Suk Kim, Sang-Won Park, Hong Bin Kim, Nam Joong Kim, Myoung-don Oh, Kang Won Choe
Infect Chemother.2012;44(3):175-179.   Published online 2012 June 30     DOI: http://dx.doi.org/10.3947/ic.2012.44.3.175
      
3 Incidence of Atazanavir-associated Hyperbilirubinemia in Korean HIV Patients: 30 Months Follow-up Results in a Population with Low UDP-glucuronosyltransferase1A1*28 Allele Frequency
Pyoeng Gyun Choe, Wan Beom Park, Jin Su Song, Nak-Hyun Kim, Kyoung-Ho Song, Sang Won Park, Hong Bin Kim, Nam Joong Kim, Myoung-don Oh
J Korean Med Sci.2010;25(10):1427-1430.   Published online 2010 September 17     DOI: http://dx.doi.org/10.3346/jkms.2010.25.10.1427
      
4 Two Cases of Multidrug-Resistant Human Immunodeficiency Virus Infection Treated with Atazanavir and Lopinavir/Ritonavir Combination Therapy
Heekyoung Choi, Su Jin Jeong, Han Sung Lee, Bum Sik Chin, Suk Hoon Choi, Sang Hoon Han, Myung Soo Kim, Chang Oh Kim, Jun Yong Choi, Young Goo Song, June Myung Kim
J Korean Med Sci.2008;23(4):737-739.   Published online 2008 August 25     DOI: http://dx.doi.org/10.3346/jkms.2008.23.4.737
      

 1 of 1